Hemophilia Q&A


Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.

Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.

Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.

Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.
New survey fielded by Excellence in Pediatrics Institute, with support from Pfizer, aims to uncover challenges and find solutions to gaps in pediatric vaccination rates in Europe.

New survey fielded by Excellence in Pediatrics Institute, with support from Pfizer, aims to uncover challenges and find solutions to gaps in pediatric vaccination rates in Europe.